Select for export Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03693-w PubMed 41257994 Copy citation Copy BibTeX Translational Psychiatry 2025-11-12 Marieke Martens, Bruna Giribaldi Cunha, David Erritzøe, David Nutt, Robin Carhart-Harris, Catherine J. Harmer OpenAlex Published psilocybin DepressionChronic PainMechanism of Action Randomized Controlled Trial More
Select for export A lexicon for psychedelic research and treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245251380511 Copy citation Copy BibTeX Drug Science Policy and Law 2025-08-31 David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida OpenAlex Published psilocybin DepressionPharmacologyMicrodosing Clinical Trial More
Select for export Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2025.1594307 PubMed 40842948 Copy citation Copy BibTeX Frontiers in Psychiatry 2025-08-05 Grace Blest-Hopley, Giuseppe Pasculli, Simon Ruffell, WaiFung Tsang, Olateju Emmanuel, Kathryn M. Pate OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.comppsych.2025.152619 PubMed 40618640 Copy citation Copy BibTeX Comprehensive Psychiatry 2025-07-01 Luca Pellegrini, Naomi Fineberg, Sorcha O'Connor, Ana Maria Frota Lisbôa Pereira de Souza, Kate Godfrey, Sara Reed OpenAlex Published psilocybin DepressionOCDChronic Pain Clinical Trial More
Select for export The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjp.2025.102 PubMed 40528492 Copy citation Copy BibTeX The British Journal of Psychiatry 2025-06-17 Kyle T. Greenway, Nicolas Garel, Lê-Anh Dinh-Williams, Julien Thibault Lévesque, Mendel Kaelen, Vincent Dagenais-Beaulé OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Randomized Controlled Trial More
Select for export Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyg.2025.1580663 PubMed 40547590 Copy citation Copy BibTeX Frontiers in Psychology 2025-06-05 William Roseby, Hannes Kettner, Leor Roseman, Meg J. Spriggs, Taylor Lyons, Joe Peill OpenAlex Published psilocybin DepressionChronic PainMechanism of Action Clinical Trial More
Select for export Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-025-03035-8 PubMed 40281226 Copy citation Copy BibTeX Molecular Psychiatry 2025-04-25 Rebecca Harding, Neomi Singer, Matthew B. Wall, Talma Hendler, David Erritzøe, David Nutt OpenAlex Published psilocybin DepressionAnxietyBrain Imaging Other More
Select for export Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2025.105421 Copy citation Copy BibTeX Neuroscience Applied 2024-12-31 Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe OpenAlex Published psilocybin DepressionBrain Imaging Other More
Select for export Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eclinm.2024.102799 PubMed 39764567 Copy citation Copy BibTeX EClinicalMedicine 2024-09-22 David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-024-66817-0 PubMed 39019922 Copy citation Copy BibTeX Scientific Reports 2024-07-16 Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Psychedelics and the ‘inner healer’: Myth or mechanism? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241239206 PubMed 38605658 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-04-11 Joseph Peill, M. Marguilho, David Erritzøe, Tommaso Barba, Kyle T. Greenway, Fernando E. Rosas OpenAlex Published psilocybin DepressionChronic PainMechanism of Action Randomized Controlled Trial More
Select for export Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241237870 PubMed 38520045 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-03-21 David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11469-024-01253-9 Copy citation Copy BibTeX International Journal of Mental Health and Addiction 2024-03-06 Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2024.02.089 PubMed 38423367 Copy citation Copy BibTeX Journal of Affective Disorders 2024-02-26 Débora Copa, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, Enzo Tagliazucchi OpenAlex Published psilocybin DepressionBrain ImagingDefault Mode Network Other More
Select for export Psychedelics and sexual functioning: a mixed-methods study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-023-49817-4 PubMed 38326446 Copy citation Copy BibTeX Scientific Reports 2024-02-06 Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph Peill, Leor Roseman, David Nutt OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s0033291723003653 PubMed 38247730 Copy citation Copy BibTeX Psychological Medicine 2024-01-21 Balázs Szigeti, Brandon Weiss, Fernando E. Rosas, David Erritzøe, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Psilocybin vs Escitalopram for depression: 6-month follow-up No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2024.104377 Copy citation Copy BibTeX Neuroscience Applied 2023-12-31 Thomas Barba, David Erritzøe, Kyle T. Greenway, Rinki Murphy, John Martell, Christopher Timmermann OpenAlex Published psilocybin DepressionAnxiety Other More
Select for export Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s0033291723001514 PubMed 37264814 Copy citation Copy BibTeX Psychological Medicine 2023-06-01 Brandon Weiss, Induni Ginige, Lu Shannon, Bruna Giribaldi, Ashleigh Murphy-Beiner, Roberta Murphy OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231167848 PubMed 37122239 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-04-24 Brandon Weiss, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2022.0002 PubMed 37337526 Copy citation Copy BibTeX Psychedelic Medicine 2022-10-27 Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM Europe PMC Published psilocybin Depression Other More
